Literature DB >> 20041058

The effect of hyaluronic Acid on the invasiveness of malignant glioma cells : comparison of invasion potential at hyaluronic Acid hydrogel and matrigel.

Shu-Guang Jin1, Young-Il Jeong, Shin Jung, Hyang-Hwa Ryu, Yong-Hao Jin, In-Young Kim.   

Abstract

OBJECTIVE: Hyaluronidase (HAse), a degrading enzyme of hyaluronic acid (HA), is highly expressed in patients with malignant glioma. The purpose of this study was to verify whether HAse is related to the invasion of glioma cells. We also investigated if glioma cells with higher mobility in 2-dimensioal (2-D) method have also higher mobility at 3-dimensional (3-D) environment.
METHODS: Malignant glioma cell lines (U87MG, U251MG, U343MG-A, and U373MG) were used, and their HAse expressions were evaluated by HA zymography. The migration ability was evaluated by simple scratch technique. The invasiveness of each cell lines was evaluated by Matrigel invasion assay and HA hydrogel invasion assay. In HA hydrogel invasion assay, colonies larger than 150 microm were regarded as positive ones and counted. Statistical analysis of migration ability and invasion properties of each cell lines was performed using t-test.
RESULTS: In scratch test to examine migration ability of each cell lines, U87MG cells were most motile than others, and U343MG-A least motile. The HAse was expressed in U251MG and U343MG-A cell lines. However, U87MG and U373MG cell lines did not express HAse activity. In Matrigel invasion assay, the cell lines expressing HAse (U251MG and U343MG-A) were more invasive in the presence of HA than HAse deficient cell lines (U87MG and U373MG). In HA hydrogel invasion assay, the HAse-expressing cell lines formed colonies more invasively than HAse-deficient ones.
CONCLUSION: Malignant Glioma cells expressing HAse were more invasive than HAse-deficient ones in 3-dimensional environment. Therefore, it might be suggested that invasion of malignant gliomas is suppressed by inhibition of HAse expression or HA secretion. Additionally, the ability of 2-D migration and 3-D invasion might not be always coincident to each other in malignant glioma cells.

Entities:  

Keywords:  Hyaluronic acid; Hyaluronic acid hydrogel; Hyaluronidase; Invasion; Malignant glioma; Migration

Year:  2009        PMID: 20041058      PMCID: PMC2796354          DOI: 10.3340/jkns.2009.46.5.472

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  24 in total

Review 1.  Brain extracellular matrix.

Authors:  E Ruoslahti
Journal:  Glycobiology       Date:  1996-07       Impact factor: 4.313

2.  Glioma invasion in vitro is mediated by CD44-hyaluronan interactions.

Authors:  B Radotra; D McCormick
Journal:  J Pathol       Date:  1997-04       Impact factor: 7.996

Review 3.  Functions of hyaluronan.

Authors:  T C Laurent; U B Laurent; J R Fraser
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

4.  Use of the Matrigel-based assay to measure the invasiveness of leukemic cells.

Authors:  M Janiak; H R Hashmi; A Janowska-Wieczorek
Journal:  Exp Hematol       Date:  1994-07       Impact factor: 3.084

5.  Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.

Authors:  D Liu; E Pearlman; E Diaconu; K Guo; H Mori; T Haqqi; S Markowitz; J Willson; M S Sy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 6.  HA receptors: regulators of signalling to the cytoskeleton.

Authors:  J Entwistle; C L Hall; E A Turley
Journal:  J Cell Biochem       Date:  1996-06-15       Impact factor: 4.429

7.  Glioblastoma cells do not intravasate into blood vessels.

Authors:  J J Bernstein; C A Woodard
Journal:  Neurosurgery       Date:  1995-01       Impact factor: 4.654

Review 8.  Hyaluronan-binding proteins in development, tissue homeostasis, and disease.

Authors:  C B Knudson; W Knudson
Journal:  FASEB J       Date:  1993-10       Impact factor: 5.191

9.  Some observations on the localization of hyaluronic acid in adult, newborn and embryonal rat brain.

Authors:  A Bignami; R Asher
Journal:  Int J Dev Neurosci       Date:  1992       Impact factor: 2.457

10.  Reticulated hyaluronan hydrogels: a model for examining cancer cell invasion in 3D.

Authors:  Laurent David; Virginie Dulong; Didier Le Cerf; Claude Chauzy; Vic Norris; Bertrand Delpech; Marek Lamacz; Jean-Pierre Vannier
Journal:  Matrix Biol       Date:  2004-06       Impact factor: 11.583

View more
  13 in total

1.  Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform.

Authors:  Badriprasad Ananthanarayanan; Yushan Kim; Sanjay Kumar
Journal:  Biomaterials       Date:  2011-08-05       Impact factor: 12.479

2.  Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Authors:  Jordi Martinez-Quintanilla; Derek He; Hiroaki Wakimoto; Ramon Alemany; Khalid Shah
Journal:  Mol Ther       Date:  2014-10-29       Impact factor: 11.454

Review 3.  Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models.

Authors:  Mariana R Carvalho; Daniela Lima; Rui L Reis; Joaquim M Oliveira; Vitor M Correlo
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 4.  HYDRHA: Hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering.

Authors:  Maddalena Grieco; Ornella Ursini; Ilaria Elena Palamà; Giuseppe Gigli; Lorenzo Moroni; Barbara Cortese
Journal:  Mater Today Bio       Date:  2022-10-08

Review 5.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

6.  Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.

Authors:  Forrest M Kievit; Ashleigh Cooper; Soumen Jana; Matthew C Leung; Kui Wang; Dennis Edmondson; David Wood; Jerry S H Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2013-06-17       Impact factor: 9.933

Review 7.  Identifying new small molecule anti-invasive compounds for glioma treatment.

Authors:  Jennifer Munson; Michael Bonner; Levi Fried; Jonathan Hofmekler; Jack Arbiser; Ravi Bellamkonda
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

8.  Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells.

Authors:  Do Hyung Kim; Young-Il Jeong; Chung-Wook Chung; Cy Hyun Kim; Tae Won Kwak; Hye Myeong Lee; Dae Hwan Kang
Journal:  Int J Nanomedicine       Date:  2013-04-30

9.  Strategies of Mesenchymal Invasion of Patient-derived Brain Tumors: Microenvironmental Adaptation.

Authors:  Junghwa Cha; Seok-Gu Kang; Pilnam Kim
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

10.  Release of tissue inhibitor of metalloproteinase-2 from alginate microcapsule encapsulating genetically engineered cells.

Authors:  Yeon Seong Kim; Young-Ii Jeong; Shu-Guang Jin; Jian Pei; Min Wen; In-Young Kim; Kyung-Sub Moon; Tae-Young Jung; Hyang-Hwa Ryu; Shin Jung
Journal:  Int J Nanomedicine       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.